Activation of the MN/CA9 gene is associated with hypomethylation in human renal cell carcinoma cell lines

Molecular Carcinogenesis

Volumn 27, Issue 3, 2000, Pages 184-189

  Cho, Masaki ^a   Grabmaier, Karin ^b   Kitahori, Yoshiteru ^a   Hiasa, Yoshio ^a   Nakagawa, Yoshinori ^a   Uemura, Hirotsugu ^a   Hirao, Yoshihiko ^a   Ohnishi, Takeo ^a   Yoshikawa, Kazuhiro ^c   Ooesterwijk, Egbert ^b  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Hypomethylation; MN CA9; Renal cell carcinoma

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA;

ARTICLE; CANCER CELL; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENOME; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; METHYLATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, NEOPLASM; AZACITIDINE; BASE SEQUENCE; CARCINOMA, RENAL CELL; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MOLECULAR SEQUENCE DATA; TUMOR CELLS, CULTURED;

EID: 17444450519     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(200003)27:3<184::AID-MC5>3.0.CO;2-P     Document Type: Article

References (26)

1. Oosterwijk E, Ruiter DJ, Hoedemaeker PhJ, et al. Monoclonal antibody G250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney. Int J Cancer 1986;38:489-494.
2. Pastorek J, Pastoreková S, Callebaut I, et al. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene 1994;9:2877-2888.
3. Opavsky R, Pastoreková S, Zelnik V, et al. Human MN/CA9 gene, a novel member of the carbonic anhydrase family: Structure and exon to protein domain relationships. Genomics 1996;33:480-487.
4. Uemura H, Nakagawa Y, Yoshida K, et al. MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas. Br J Cancer 1999;81:741-746.
5. Kranenborg MH, Boerman OC, de Weijert MC, Oosterwijk-Wakka JC, Corstens FH, Oosterwijk E. The effect of antibody protein dose of anti-renal cell carcinoma monoclonal antibodies in nude mice with renal cell carcinoma xenografts. Cancer 1997;80:2390-2397.
6. Mckiernan JM, Buttyan R, Bander NH, et al. Expression of the tumor-associated gene MN: A potential biomarker for human renal cell carcinoma. Cancer Res 1997;57: 2362-2365.
7. Liao S, Brewer C, Závada J, et al. Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. Am J Pathol 1994;145:598-609.
8. Saarnio J, Parkkila S, Parkkila AK, et al. Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. Am J Pathol 1998;153:279-285.
9. Pastoreková S, Parkkila S, Parkkila AK, et al. Carbonic anhydrase IX: Analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts. Gastroenterology 1997;112:398-408.
10. Wainfan E, Poirier LA, Methyl groups in carcinogenesis: Effects on DNA methylation and gene expression. Cancer Res 1992;52:2071s-2077s.
11. Lipsanen V, Leinonen P, Alhonen L, Jaenne J. hypomethylation of ornithine decarboxylase gene and erb-A1 oncogene in human chronic lymphatic leukemia, Blood 1988;72: 2042-2044.
12. Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC. Bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphatic leukemia. Blood 1993;82: 1820-1828.
13. Smet CD, Backer OD, Faraoni I, Lurquin C, Brasseur F, Boon T. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci USA 1996;93:7149-7153.
14. Zingg JM, Jones PA. Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis 1997;18:869-882.
15. Cedar H. DNA methylation and gene activity. Cell 1988; 53:3-4.
16. Ebert T, Bander NH, Finstad CL, Ramsawak RD, Old LJ. Establishment and characterization of human renal cancer and normal kidney cell lines. Cancer Res 1990;50: 5531-5536.
17. Cho M, Konishi N, Yamamoto K, et al. Genomic aberrations in renal cell carcinomas detected by restriction landmark genomic scanning. Eur J Cancer 1998;34:2112-2118.
18. Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994;22:2990-2997.
19. Lieskovaska J, Opavsky R, Zacikova L, Glasova M, Pastorek J. Pastoreková S. Study of in vitro conditions modulating expression of MN/CA IX protein in human cell lines derived from cervical carcinoma. Neoplasma 1999;46:17-24.
20. Meehan R, Lewis J, Cross S, Nan X, Jeppesen P, Bird A. Transcriptional repression by methylation of CpG. J Cell Sci Suppl 1992;16:9-14.
21. Jones PL, Veenstra GC, Wade PA, et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 1998;19:187-191.
22. Harris M. Induction of thymidine kinase in enzyme deficient Chinese hamster cells. Cell 1982;29:483-492.
23. Jones PA, Taylor SM. Cellular differentiation, cytidine analogs, and DNA methylation. Cell 1995;20:85-93.
24. Ivanov SV, Kuzmin I, Wei MH, et al. Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. Proc Natl Acad Sci USA 1998;95:12596-12601.
25. Lowe N, Brady HJM, Barlow JH, Sowden JC, Edwards M, Butterworth PHW. Structure and methylation patterns of the gene encoding human carbonic anhydrase I Gene 1990;93:277-283.
26. Edwards YH, Charlton J, Brownson C. A non-methylated CpG-rich island associated with the human muscle-specific carbonic anhydrase III gene. Gene 1988;71: 473-481.